*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Bortezomib is a potent <strong>proteasome inhibitor</strong> used in oncology. Synthesized via complex peptide chemistry, its molecular formula is C<sub>21</sub>H<sub>28</sub>N<sub>4</sub>O<sub>6</sub>S and CAS No. 179324-69-7.</p>
<h3>Application</h3>
<ul>
<li><strong>Hematologic Malignancies:</strong> First-line treatment for multiple myeloma and mantle cell lymphoma.</li>
<li><strong>Clinical Research:</strong> Investigated for solid tumor combinations and drug resistance mechanisms.</li>
</ul>
<h3>Precautions</h3>
<p>Requires strict cold chain storage at -20°C. Clinical use mandates monitoring for peripheral neuropathy, thrombocytopenia, and hypertension. Handling requires PPE to prevent dermal absorption.</p>